Search

everythinglearnresearchcommunity

for

Search:↓

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Some supplements and hormones can increase hair loss by raising DHT levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

The dog had a Sertoli cell tumor, which was successfully removed with surgery.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

The method shows hair testosterone levels reflect those in saliva, but are affected by various factors and may indicate a risk for heart attack.

Feminizing hormone therapy increases kidney filtration rate.

Early-onset male baldness may increase the risk of metabolic syndrome.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

The rs6152 allele is not a good marker for baldness in the Indonesian population, but family history, age, gender, high blood pressure, and body weight are linked to the risk.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Men may have a condition similar to PCOS, possibly indicated by early hair loss.